Search
The use of artificial intelligence (AI) to create works of art and inventions raises interesting legal challenges to the protection of intellectual property (IP). The plain language of the Copyright Act and Patent Act present obstacles to inventors and artists who may use or be AI systems. Recent...
Saul Ewing is a proud sponsor of the M&A East Conference held by the Philadelphia Chapter of the Association of Corporate Growth. M&A East attracts top strategic and financial dealmakers as well as leading middle market advisors and provides an environment for valuable networking. The conference...
Kathryn Doyle, Partner at Saul Ewing LLP, will be presenting at the NACUA Annual Meeting, June 26-29, 2022, in Pittsburgh. She will be speaking on June 28, 9:15-10:30 a.m., on the topic "You Thought You Owned It, They Might Have Stolen It, and a Medley of Inventor Kerfuffles”. Joining Kathryn will...
Washington, D.C., November 24, 2021 – Saul Ewing LLP served as counsel to Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the successful completion today of its previously announced $450 million acquisition of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS). The acquisition strengthens Supernus'...
![Profile placeholder image - dark gray graphic silhouette over light gray background](/sites/default/files/styles/card_410x307_/public/images/2022-08/profile_placeholder_small.jpg?h=a7b36234&itok=cJK1OEOo)
Veronica McCarty is a litigator who represents inventors and companies in intellectual property disputes, particularly for inventions involving computing and biopharmaceutical technologies, as well as medical devices. Veronica works on patent trials, including on ANDA bench trials, and she assists...
Industry-Specific, Business-Focused Legal Advice Increased pricing pressure combined with a rise in generic competition and continued regulatory uncertainty have squeezed the margins of life sciences companies. Helping navigate this ever-shifting terrain, Saul Ewing’s Life Sciences Practice consists...
![Caroline Patterson](/sites/default/files/styles/card_410x307_/public/images/2024-02/Patterson_Caroline_LinkedIn.jpg?h=753774cc&itok=uBXv3MWN)
Caroline Patterson brings more than 25 years of legal experience to her work representing practices and professionals in the health care industry in a variety of transactional, corporate, and regulatory matters. Her experience ranges from providing counsel in mergers, acquisitions, sales and private...
![Kathryn Doyle](/sites/default/files/styles/card_410x307_/public/images/2022-08/Doyle_Kathryn_LinkedIn.jpg?h=40c24adf&itok=CWxgEisc)
A life sciences patent attorney with a Ph.D. in virology and cell and molecular biology, Kathryn Doyle represents universities and companies throughout the United States in identifying, protecting and enforcing their intellectual property in the areas of biotechnology, pharmaceuticals, agriculture...
![David R. Berk](/sites/default/files/styles/card_410x307_/public/images/2022-09/Berk_David_LinkedIn.jpg?h=40c24adf&itok=nWI0e_Qn)
David Berk counsels families and their businesses, entrepreneurs and start-up companies in taxation, structuring transactions, contract negotiations and governance issues. David also advises clients on corporate succession planning, trust and estate planning, insurance and retirement planning and...
![Jeffrey W. Letwin](/sites/default/files/styles/card_410x307_/public/images/2022-09/Letwin_Jeffrey_LinkedIn.jpg?h=72da4a73&itok=YuaGzNwR)
Jeffrey Letwin counsels businesses in complex matters including corporate finance, mergers and acquisitions, franchising, real estate finance and development. He also advises enterprises in the interface between governmental and economic development agencies and devises financing strategies...
![Eric G. Orlinsky Headshot](/sites/default/files/styles/card_410x307_/public/images/2022-08/Orlinsky_Eric_LinkedIn.jpg?h=40c24adf&itok=dje76Rlz)
Eric Orlinsky co-chairs the firm's Corporate Practice and its Private Equity/Venture Capital subgroup and concentrates his practice in general business and securities law and counsels clients in private equity and venture capital investments, public and private offerings of debt and equity...